Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE2544.15116.9 (+4.82 %)
PREV CLOSE () 2427.25
OPEN PRICE () 2430.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 180494
TODAY'S LOW / HIGH ()2430.00 2550.00
52 WK LOW / HIGH ()1575 2574
NSE2543.70115.4 (+4.75 %)
PREV CLOSE() 2428.30
OPEN PRICE () 2428.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2543.70 (7)
VOLUME 841656
TODAY'S LOW / HIGH() 2428.70 2550.00
52 WK LOW / HIGH ()1573.6 2573.5
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1978

Management Info :

Srinivas Sadu - Chairman - Managing Director

Registered Office :

Address : Survey No. 143-148, 150 & 151, Near Gandimaisamma ‘x’ Roads,D. P. Pally, Dundigal, Dundigal-gandimaisamma Mandal,Medchal- Malkajgiri District,
Hyderabad,
Telangana-500043

Phone : 040 30510999

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
29Jul Gland Pharma gets USFDA’s approval for
Gland Pharma has received approval from the United States Food and Drug..
29Jul Gland Pharma informs about press release
Gland Pharma has informed that it enclosed press release titled ‘Gland P..
29Jul Gland Pharma trades higher on getting
Gland Pharma is currently trading at Rs. 2487.80, up by 60.55 points or..
25Jul Gland Pharma informs about board meeting
Gland Pharma has informed that the meeting of the Board of Directors of..
02Jun Gland Pharma informs about allotment
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit4204.5112995.51
Gross Profit 5647.99 17483.11
Operating Profit 6140.7419669.73
Net Sales 12615.9245520.92
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 19716.30 (4.54%)
M.Cap ( in Cr)
25295.79
Divi's Laboratories (BSE)
 7794.00 (5.03%)
M.Cap ( in Cr)
206906.21
Astrazeneca Pharma (BSE)
 8179.35 (1.36%)
M.Cap ( in Cr)
20448.38
Glenmark Pharma. (BSE)
 2261.95 (3.53%)
M.Cap ( in Cr)
63832.41
Concord Biotech (BSE)
 1330.10 (6.05%)
M.Cap ( in Cr)
13915.00
Shareholding Pattern
PROMOTERS 51.77%
MUTUAL FUNDS/UTI 28.23%
NON-INSTITUTION 9.05%
FI/BANKS/INSURANCE 1.28%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX77654.60888.68 (1.16%)
NIFTY24250.20264.85 (1.10%)
Dow Jones 52747.32537.24 (1.03%)
Nasdaq 24876.91-55.17 (-0.22%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI